Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients

Clove (Syzygium aromaticum flower buds) EtOH extract significantly suppressed an increase in blood glucose level in type 2 diabetic KK-Ay mice. In-vitro evaluation showed the extract had human peroxisome proliferator-activated receptor (PPAR)-γ ligand-binding activity in a GAL4-PPAR-γ chimera assay....

Full description

Saved in:
Bibliographic Details
Published in:Journal of natural medicines Vol. 66; no. 2; pp. 394 - 399
Main Authors: Kuroda, Minpei, Mimaki, Yoshihiro, Ohtomo, Takayuki, Yamada, Junji, Nishiyama, Tozo, Mae, Tatsumasa, Kishida, Hideyuki, Kawada, Teruo
Format: Journal Article
Language:English
Published: Japan Springer-Verlag 01-04-2012
Springer Japan
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clove (Syzygium aromaticum flower buds) EtOH extract significantly suppressed an increase in blood glucose level in type 2 diabetic KK-Ay mice. In-vitro evaluation showed the extract had human peroxisome proliferator-activated receptor (PPAR)-γ ligand-binding activity in a GAL4-PPAR-γ chimera assay. Bioassay-guided fractionation of the EtOH extract resulted in the isolation of eight compounds, of which dehydrodieugenol (2) and dehydrodieugenol B (3) had potent PPAR-γ ligand-binding activities, whereas oleanolic acid (4), a major constituent in the EtOH extract, had moderate activity. Furthermore, 2 and 3 were shown to stimulate 3T3-L1 preadipocyte differentiation through PPAR-γ activation. These results indicate that clove has potential as a functional food ingredient for the prevention of type 2 diabetes and that 2–4 mainly contribute to its hypoglycemic effects via PPAR-γ activation.
Bibliography:http://dx.doi.org/10.1007/s11418-011-0593-z
ISSN:1340-3443
1861-0293
DOI:10.1007/s11418-011-0593-z